A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01934673

Acronym

DiabCare Asia

Enrollment

1668

Registered

2013-09-04

Start date

2013-09-30

Completion date

2013-11-30

Last updated

2014-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this non-interventional study is to evaluate the current status of diabetes management, control, and complications in subjects with type 2 diabetes in Malaysia.

Interventions

OTHERNo treatment given

Patients will fill out a questionnaire by interview.

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* People with type 2 diabetes mellitus (DM) who are being treated, with any of the non-pharmacological or pharmacological options, at a particular centre for at least 2 years and who have visited the centre within the last 3-6 months * Patients willing to sign informed consent form

Exclusion criteria

* Previous participation in this study * Unable to comply with protocol requirements * Confirmed or suspected pregnancy

Design outcomes

Primary

Measure	Time frame
Proportion of patients having HbA1c ((glycosylated haemoglobin) as measured during survey) less than 7%	Evaluated at the first visit (only one study visit)

Secondary

Measure	Time frame
Mean Postprandial Plasma Glucose (PPG) of patients	Evaluated at the first visit (only one study visit)
Mean HbA1c of patients	Evaluated at the first visit (only one study visit)
Proportion of patients having dyslipidemia	Evaluated at the first visit (only one study visit)
Proportion of patients having hypertension	Evaluated at the first visit (only one study visit)
Mean Fasting Plasma Glucose (FPG) of patients	Evaluated at the first visit (only one study visit)
Proportion of patients having peripheral vascular disease	Evaluated at the first visit (only one study visit)
Proportion of patients having diabetic nephropathy	Evaluated at the first visit (only one study visit)
Proportion of patients having diabetic eye complications	Evaluated at the first visit (only one study visit)
Proportion of patients having cardiovascular complications	Evaluated at the first visit (only one study visit)

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026